CJ Filed Injunction To End Trademark Dispute

In an effort to put a final closure on its controversial trademark dispute with Hanmi Pharmaceutical, CJ Pharmaceutical Division filed for an injunction with the Seoul Central District Court on December 6th.

The Korea Intellectual Property Office (KIPO) made a decision on September 30th of this year to grant a registration of CJ’s trademark Simvastar (simvastatin), a generic product whose no...